Impact of Diabetes Mellitus on Percutaneous Coronary Intervention Outcomes: Real-World Lessons From a Large Chinese Single-Center Registry

Abstract

Get full access to this article

View all access options for this article.

References

Zhang

Liu

. Coronary heart disease in China. Heart. 2008;94:1126–31.

Zheng

Curtis

. Coronary catheterization and percutaneous coronary intervention in China: 10-year results from the China PEACE-Retrospective CathPCI Study. JAMA Intern Med. 2016;176:512–21.

Yan

Jiang

. ST-segment elevation myocardial infarction in the eastern urban China: from 2001 to 2011 [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44:303–8.

Zheng

Bai

Huo

. Percutaneous coronary intervention in eastern urban China: 2001-2011 [in Chinese]. Zhonghua Yi Xue Za Zhi. 2016;96:1863–70.

Jiang

Han

Gao

. Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: a retrospective study. Medicine (Baltimore). 2017;96:e6647.

Zheng

Cheng

Zhang

. Association between glycosylated hemoglobin level and cardiovascular outcomes in diabetic patients after percutaneous coronary intervention. Medicine (Baltimore). 2016;95:e3696.

Wang

Gao

Song

. Impact of diabetes mellitus on percutaneous coronary intervention in Chinese patients: A Large Single-Center Data. Angiology. 2018;69(6):540–7.

Niu

Mao

Huang

. CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: a systematic review and meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2015;35:147–56.

Chen

Qin

Xie

. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China. Pharmacogenomics. 2008;9:691–702.

10.

Feng

Liang

Bai

. Clopidogrel metabolism related gene polymorphisms in Chinese patients with acute coronary syndrome [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40:908–13.

11.

Jin

Shen

Shi

. Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel. Mol Biol Rep. 2011;38:1697–702.

12.

Mao

Jian

Changzhi

. Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Arch Cardiovasc Dis. 2013;106:517–27.

13.

Liu

Yin

. CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention. Coron Artery Dis. 2014;25:412–20.

14.

Giacoppo

Colleran

Cassese

. Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis. JAMA Cardiol. 2017;2:1079–88.

15.

Jones

Gallagher

Rathod

. Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. JACC Cardiovasc Interv. 2014;7:362–71.

16.

Whitbeck

Applegate

. Second generation drug-eluting stents: a review of the everolimus-eluting platform. Clin Med Insights Cardiol. 2013;7:115–26.

17.

Meng

. Risk factors for long-term outcome of drug-eluting stenting in adults with early-onset coronary artery disease. Int J Med Sci. 2014;11:721–5.

18.

Bangalore

Bhagwat

Pinto

. Percutaneous coronary intervention in patients with insulin-treated and non-insulin-treated diabetes mellitus: secondary analysis of the TUXEDO trial. JAMA Cardiol. 2016;1:266–73.

19.

Parasca

Head

Milojevic

. Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the syntax trial at 5 years. JACC Cardiovasc Interv. 2016;9:2493–507.

20.

Farkouh

Domanski

Sleeper

. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375–84.

21.

Blumenthal

Hsiao

Blumenthal

. Caring for coronary artery disease in China: managing modernization. JAMA Intern Med. 2016;176:521–3.